14.100
−0,70%
2026-10-19
Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -51.9% | -38.4% | 0 / 3 | +4.8% | -4.69 pp | -6.39 pp | +16.9% | 0.54 | 2.27 | 337 | +4,8% | 55,0 | −24,7% | 2.27 | 4.59 | −50,5% |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 12 | 12 | |||||||
Valuation annotation:Price: 14.100 (close price on 2026-10-19)EPS (TTM): 6.205
Financial charts
1.Revenue & growth
VND bn337Q2/26
1.Revenue & growth
VND bn337Q2/26
2.Profit & growth
VND bn55,0Q2/26
3.Profit mix (Penman)
VND bn246Q2/26
4.Margins & cost structure
%29.9%Q2/26
5.Returns & cash cycle
% · days15.1%Q2/26
6.Earnings quality & cash
VND bn228Q2/26
7.Asset structure
VND bn2.817Q2/26
8.Funding & debt health
VND bn · times2.817Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %3,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %974Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q2/26